Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Microbiol.

Sec. Microbiotechnology

This article is part of the Research TopicMetabolic Engineering for the Production of Bioactive CompoundsView all 8 articles

Recent Advances in Microbial 3-Methyl-1-Butanol Production

Provisionally accepted
  • 1VIB KU Leuven Center for Microbiology, Flanders Institute for Biotechnology, Heverlee (Leuven), Belgium
  • 2Katholieke Universiteit Leuven Centrum voor Microbiele en Plantengenetica, Leuven, Belgium

The final, formatted version of the article will be published soon.

3-Methyl-1-butanol (3MB), also known as isoamyl alcohol, is an emerging bio-based solvent, platform chemical, and advanced biofuel candidate whose demand continues to grow across chemical, energy, and consumer product sectors. Microbial synthesis offers a sustainable alternative to petrochemical routes, yet achieving industrially viable titers remains challenging due to pathway complexity, byproduct formation, redox imbalance, and product toxicity. This review provides a comprehensive summary of current advances in microbial 3MB production, including host strain and pathway engineering, feedstock diversification, and fermentation design. We compare the three principal biosynthetic routes toward 3MB—the valine–leucine–Ehrlich pathway, the mevalonate pathway, and the isovaleryl-CoA pathway—and evaluate their implementation across bacterial and yeast chassis. Particular focus is placed on strategies that enhance flux through leucine biosynthesis, reduce byproduct formation such as isobutanol, and rebalance NAD(P)H cofactors. Mechanisms of 3MB toxicity and recent insights from adaptive laboratory evolution and omics analyses are discussed as emerging guides for improving product tolerance. Beyond genetic interventions, we highlight process-level opportunities such as in situ product extraction, oxygen-supply optimization, and fed-batch operation, which remain underexplored yet are critical for achieving high 3MB titers. Looking forward, leveraging isobutanol chassis strains, employing high-throughput technologies such as biosensor-guided evolution, adopting intensified fermentation strategies, and co-producing 3MB alongside bioethanol may accelerate the development of scalable and economically competitive microbial platforms for 3MB production.

Keywords: 3-methyl-1-butanol, bioethanol, Fusel alcohol, Isoamyl alcohol, isopentanol, Metabolic Engineering

Received: 25 Nov 2025; Accepted: 31 Dec 2025.

Copyright: © 2025 Yogiswara and Verstrepen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Kevin J. Verstrepen

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.